eViralHepatitis Review

eViralHepatitis Review


Volume 4, Issue 8, Part 3

May 26, 2015

Sofosbuvir/Velpatasvir fixed dose combination for 12 Weeks in Patients Co-Infected with HCV and HIV-1: The Phase 3 ASTRAL-5 Study